Found: 7
Select item for more details and to access through your institution.
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89242-z
- By:
- Publication type:
- Article
Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-77990-3
- By:
- Publication type:
- Article
Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 655, doi. 10.3390/v15030655
- By:
- Publication type:
- Article
Application of a Human Blood Brain Barrier Organ-on-a-Chip Model to Evaluate Small Molecule Effectiveness against Venezuelan Equine Encephalitis Virus.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 12, p. 2799, doi. 10.3390/v14122799
- By:
- Publication type:
- Article
Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 2, p. 271, doi. 10.3390/v13020271
- By:
- Publication type:
- Article
Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 9, p. 1021, doi. 10.3390/v12091021
- By:
- Publication type:
- Article
Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 12, p. 1151, doi. 10.3390/v11121151
- By:
- Publication type:
- Article